Calame, D. | Search bioRxiv

bioRxiv2020

QUANTIFICATION OF MOUSE REACH KINEMATICS AS A FOUNDATION FOR MECHANISTIC INTERROGATION OF MOTOR CONTROL

Mice use reaching movements to grasp and manipulate objects in their environment, similar to primates. Thus, many recent studies use mouse reach to uncover neural control mechanisms, but quantification of mouse reach kinematics remains lacking, limiting understanding. Here we implement several analytical frameworks, from basic kinematic relationships to statistical machine learning, to quantify mouse reach kinematics across freely-behaving and head-fixed conditions. Overall, we find that many canonical features of primate reaches are conserved in mice, with some notable differences. Our results highlight the decelerative phase of reach as important in driving successful outcome. Late-phase kinematic adjustments are yoked to mid-flight position and velocity of the limb, allowing dynamic correction of initial variability, with head-fixed reaches being less dependent on position. Furthermore, consecutive reaches exhibit positional error-correction but not hot-handedness, implying opponent regulation of motor variability. Overall, our results establish foundational mouse reach kinematics in the context of neuroscientific investigation.

neuroscience↗

bioRxiv2019

De novo EIF2AK1 and EIF2AK2 variants are associated with developmental delay, leukoencephalopathy, and neurologic decompensation

EIF2AK1 and EIF2AK2 encode members of the Eukaryotic Translation Initiation Factor 2 Alpha Kinase (EIF2AK) family that inhibits protein synthesis in response to physiologic stress conditions. EIF2AK2 is also involved in innate immune response and the regulation of signal transduction, apoptosis, cell proliferation, and differentiation. Despite these findings, human disorders associated with deleterious variants in EIF2AK1 and EIF2AK2 have not been reported. Here, we describe the identification of eight unrelated individuals with heterozygous de novo missense variants in EIF2AK1 (1/8) or EIF2AK2 (7/8). Features seen in these eight individuals include white matter alterations (8/8), developmental delay (8/8), impaired language (8/8), cognitive impairment (7/8), ataxia (6/8), dysarthria in probands with verbal ability (6/6), hypotonia (6/8), hypertonia (5/8), and involuntary movements (3/8). Individuals with EIF2AK2 variants also exhibit neurological regression in the setting of febrile illness or infection. We use mammalian cell lines and patient-derived fibroblasts to further confirm the pathogenicity of variants in these genes and found reduced kinase activity. EIF2AKs phosphorylate Eukaryotic Translation Initiation Factor 2 Subunit 1, (EIF2S1, also known as EIF2), which then inhibits EIF2B activity. Deleterious variants in genes encoding EIF2B proteins cause childhood ataxia with central nervous system hypomyelination/vanishing white matter disease (CACH/VWM), a leukoencephalopathy characterized by neurologic regression in the setting of febrile illness and other stressors. Our findings indicate that EIF2AK2 missense variants cause a neurodevelopmental syndrome that may share phenotypic and pathogenic mechanisms with CACH/VWM.

genetics↗